Mga Batayang Estadistika
| LEI | 529900O1OR2EB7L0HY27 |
| CIK | 1038133 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Heska Corp. (Restricted Voting)
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| June 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-22427 HESKA CORPORATION (Exact name of registrant as specified in its cha |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
Exhibit 99.1 Mars Completes Acquisition of Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions Heska becomes part of Mars Petcare’s Science & Diagnostics division to broaden access to diagnostics and technology, accelerate R&D and innovation, and better serve more veterinary professionals and pets. McLean, VA, June 13, 2023— Mars, Incorporated (“Mars”) today announced |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2023 HESKA CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2023 HESKA CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 13, 2023 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF HESKA CORPORATION A Delaware Corporation Effective June 13, 2023 TABLE OF CONTENTS Page ARTICLE I OFFICES Section 1. Registered Office 1 Section 2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 1. Place of Meetings 1 Section 2. Annual Meetings 2 Section 3. Special Meetings 2 Section 4. Notice 2 Section 5. Adjournments and Postponements 3 Sec |
|
| June 13, 2023 |
Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION HESKA CORPORATION June 13, 2023 Pursuant to Sections 242 and 245 of the Delaware General Corporation Law Heska Corporation (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “GCL”), does hereby certify as follows: (1) The name of the Corporation is Heska Corporation. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 13, 2023 |
Exhibit 4.1 SUPPLEMENTAL INDENTURE Reference is made to that certain Indenture dated as of September 17, 2019 (the “Indenture”), governing the 3.750% Convertible Senior Notes due 2026 of Heska Corporation, a Delaware corporation (the “Company”), between the Company and U.S. Bank Trust Company, National Association (as successor trustee to U.S. Bank National Association), as trustee (in such capaci |
|
| June 13, 2023 |
As filed with the Securities and Exchange Commission on June 13, 2023 As filed with the Securities and Exchange Commission on June 13, 2023 Registration No. |
|
| June 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 HESKA CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Num |
|
| June 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 June 1, 2023 (May 30, 2023) Date of Report (Date of Earliest Event Reported) HESKA CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commi |
|
| June 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). ☐ Definitive Proxy Sta |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 26, 2023 Date of Report (Date of Earliest Event Reported) HESKA CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). ☐ Definitive Proxy Sta |
|
| May 8, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA COR |
|
| May 5, 2023 |
Heska Corporation Reports First Quarter 2023 Results Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports First Quarter 2023 Results LOVELAND, CO, May 5, 2023 - Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results for its first quarter ended March 31, 2023. First |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 5, 2023 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commi |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 3, 2023 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commi |
|
| April 28, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). ☐ |
|
| April 28, 2023 |
Exhibit 107 CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) Heska Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee rate Amount of Filing Fee Fees to be Paid $ 1,497,333,884. |
|
| April 3, 2023 |
Exhibit 2.2 Execution Version Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Ite |
|
| April 3, 2023 |
Exhibit 99.2 Mars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions The combination of highly complementary businesses and teams will broaden access to diagnostics and technology, accelerate R&D and innovation, and better serve more veterinary professionals and pets. McLean, VA and Loveland, CO, April 3, 2023 — Mars, Incorporated (“Mars”), and Heska Corpor |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 3, 2023 (March 31, 2023) Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| April 3, 2023 |
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among HESKA CORPORATION, ANTECH DIAGNOSTICS, INC., HELSINKI MERGER SUB LLC and (solely for the purpose of Section 9.15) MARS, INCORPORATED Dated as of March 31, 2023 TABLE OF CONTENTS Page Article I Definitions Section 1.1 Certain Specified Definitions 2 Section 1.2 Defined Terms 11 Article II The Merger Section 2.1 The Merger 15 Se |
|
| April 3, 2023 |
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among HESKA CORPORATION, ANTECH DIAGNOSTICS, INC., HELSINKI MERGER SUB LLC and (solely for the purpose of Section 9.15) MARS, INCORPORATED Dated as of March 31, 2023 TABLE OF CONTENTS Page Article I Definitions Section 1.1 Certain Specified Definitions 2 Section 1.2 Defined Terms 11 Article II The Merger Section 2.1 The Merger 15 Se |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 3, 2023 |
Exhibit 99.2 Mars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions The combination of highly complementary businesses and teams will broaden access to diagnostics and technology, accelerate R&D and innovation, and better serve more veterinary professionals and pets. McLean, VA and Loveland, CO, April 3, 2023 — Mars, Incorporated (“Mars”), and Heska Corpor |
|
| April 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 3, 2023 (March 31, 2023) Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| April 3, 2023 |
Exhibit 2.2 Execution Version Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Ite |
|
| April 3, 2023 |
Exhibit 99.1 Execution Version VOTING AGREEMENT VOTING AGREEMENT (this “Agreement”), dated as of March 31, 2023, among Antech Diagnostics, Inc., a California corporation (“Acquiror”), and [●] and [●] (collectively, “Stockholder”), stockholders of Heska Corporation, a Delaware corporation (the “Company”). WHEREAS, as of the date hereof, the Stockholder is the record or “beneficial” owner (as define |
|
| April 3, 2023 |
Exhibit 99.1 Execution Version VOTING AGREEMENT VOTING AGREEMENT (this “Agreement”), dated as of March 31, 2023, among Antech Diagnostics, Inc., a California corporation (“Acquiror”), and [●] and [●] (collectively, “Stockholder”), stockholders of Heska Corporation, a Delaware corporation (the “Company”). WHEREAS, as of the date hereof, the Stockholder is the record or “beneficial” owner (as define |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [] |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 February 28, 2023 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) |
|
| February 28, 2023 |
Exhibit 21.1 SUBSIDIARIES OF COMPANY Diamond Animal Health, Inc., an Iowa corporation BioTech Laboratories U.S.A. LLC, a Delaware limited liability company Heska AG, a corporation incorporated under the laws of Switzerland Heska Canada, Limited, a limited company organized under the laws of British Columbia, Canada Heska Australia Pty Ltd, a proprietary company organized under the laws of Australi |
|
| February 28, 2023 |
Employment Agreement between Registrant and Anthony Providenti, effective as of June 20, 2020 Exhibit 10.31 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into and effective on June 20, 2021, by and between Heska Corporation, a Delaware corporation (“Heska”), and Anthony Providenti (“Executive”). This Agreement refers to Heska and Executive collectively as the “Parties” and individually as a “Party.” RECITALS WHEREFORE, Heska desires to employ Executive as Exec |
|
| February 28, 2023 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Fourth Quarter and Full Year 2022 Results Full Year Sales $257.3 Million, Full Year Gross Margin Up 150 Basis Points to 43.2% Full Year North America Lab Consumables Sales Up 8.7%, Total Active Subscriptions Up 18% LOVELAND, CO, February 28, 2023 - Heska Corporation (NAS |
|
| February 28, 2023 |
Exhibit 4.2 HESKA CORPORATION DESCRIPTION OF SECURITIES DESCRIPTION OF COMMON STOCK General The following description summarizes important terms of our common stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth herein, you should refer to our Certificate of Incorporation and our bylaws, both |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA CORPORAT |
|
| February 14, 2023 |
HSKA / Heska Corp / ALGER ASSOCIATES INC - HESKA CORPORATION Passive Investment Heska Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Heska Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 42805E306 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| February 9, 2023 |
HSKA / Heska Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Heska Corp. Title of Class of Securities: Common Stock CUSIP Number: 42805E306 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13 |
|
| February 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 January 27, 2023 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| November 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 8, 2022 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| November 8, 2022 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Third Quarter 2022 Results North America Point of Care Lab Consumables up 11.4%, Consolidated Gross Margin up 180 bps LOVELAND, CO, November 8, 2022 - Heska Corporation (NASDAQ: HSKA; ?Heska? or the ?Company?), a leading global provider of advanced veterinary diagnostic |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA |
|
| November 8, 2022 |
Exhibit 2.5 Certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K. Amendment No. 1 to Agreement and Plan of Merger This Amendment No. 1 to Agreement and Plan of Merger (this ?Amendment?) is made as of October 24, 2022 by and among Heska Corporation, a Delaware corporati |
|
| November 8, 2022 |
Exhibit 2.4 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under |
|
| September 13, 2022 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 September 9, 2022 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) |
|
| August 8, 2022 |
Amendment to Heska Corporation Equity Incentive Plan, effective May 4, 2022. Exhibit 10.1 AMENDMENT TO HESKA CORPORATION EQUITY INCENTIVE PLAN WHEREAS, Heska Corporation, a Delaware corporation (the ?Company?) maintains the Heska Corporation Equity Incentive Plan (the ?Plan?); and WHEREAS, pursuant to Article 16 thereof, the Board may, at any time and for any reason, amend the Plan, subject to the approval of the Company?s stockholders where required by law or exchange lis |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA CORP |
|
| August 8, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 August 8, 2022 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| August 8, 2022 |
Exhibit 107.1 Calculation of Filing Fee Tables FORM S-8 (Form Type) HESKA CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title (1) Fee Calculation Rule (2) Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, par value |
|
| August 8, 2022 |
As filed with the Securities and Exchange Commission on August 8, 2022 As filed with the Securities and Exchange Commission on August 8, 2022 Registration No. |
|
| August 8, 2022 |
Heska Corporation Reports Second Quarter 2022 Results Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Second Quarter 2022 Results LOVELAND, CO, August 8, 2022 - Heska Corporation (NASDAQ: HSKA; ?Heska? or the ?Company?), a leading global provider of advanced veterinary diagnostic and specialty solutions, reported financial results in two segments (North America and Inter |
|
| May 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 9, 2022 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commi |
|
| May 9, 2022 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports First Quarter 2022 Results Quarterly Revenue Up 7% (10% in Constant Currency), Gross Margin Up 290 bps North America POC Lab Consumables Up 10%, Full Year Outlook Reiterated LOVELAND, CO, May 9, 2022 - Heska Corporation (NASDAQ: HSKA; ?Heska? or the ?Company?), a leading |
|
| May 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA COR |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 4, 2022 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commi |
|
| April 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [] |
|
| March 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X |
|
| March 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [] |
|
| February 28, 2022 |
Exhibit 21.1 SUBSIDIARIES OF COMPANY Diamond Animal Health, Inc., an Iowa corporation BioTech Laboratories U.S.A. LLC, a Delaware limited liability company Heska AG, a corporation incorporated under the laws of Switzerland Heska Canada, Limited, a limited company organized under the laws of British Columbia, Canada Heska Australia Pty Ltd, a proprietary company organized under the laws of Australi |
|
| February 28, 2022 |
Exhibit 4.2 HESKA CORPORATION DESCRIPTION OF SECURITIES DESCRIPTION OF COMMON STOCK General The following description summarizes important terms of our common stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth herein, you should refer to our Certificate of Incorporation and our bylaws, both |
|
| February 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 February 28, 2022 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) |
|
| February 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA CORPORAT |
|
| February 28, 2022 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Fourth Quarter and Full Year 2021 Results Full Year Sales Up 28.6% to $253.7 Million, Record Quarterly Revenue $68.1 Million Full Year North America Lab Consumables Sales Up 21.5%, Full Year Subscriptions Up 25% LOVELAND, CO, February 28, 2022 - Heska Corporation (NASDAQ |
|
| February 16, 2022 |
Exhibit 4.12 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under |
|
| February 16, 2022 |
As filed with the Securities and Exchange Commission on February 16, 2022 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on February 16, 2022 Registration No. |
|
| February 16, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) HESKA CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Equity Common Stock, par value $0. |
|
| February 16, 2022 |
Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of Registrant. Exhibit 4.9 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, OF HESKA CORPORATION Heska Corporation (the ?Corporation?), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify: 1. This Certificate of Amendment to the Corporation?s Restated Certificate of Incorporation, as a |
|
| February 14, 2022 |
HSKA / Heska Corp / ALGER ASSOCIATES INC - HESKA CORPORATION Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Heska Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 42805E306 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 10, 2022 |
HSKA / Heska Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Heska Corp. Title of Class of Securities: Common Stock CUSIP Number: 42805E306 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule 13 |
|
| November 22, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 22, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) |
|
| November 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 4, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA |
|
| November 4, 2021 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Third Quarter 2021 Results North America Lab Consumables Sales Up 10.1% Key Strategic Initiatives Advanced, Key Markets Addressed, Key Subscriptions Metrics Achieved LOVELAND, CO, November 4, 2021 - Heska Corporation (NASDAQ: HSKA; ?Heska? or ?Company?), a leading provid |
|
| November 4, 2021 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 1, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| October 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X |
|
| October 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ |
|
| October 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [X] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ |
|
| August 4, 2021 |
Heska Corporation Equity Incentive Plan, effective May 5, 2021. Exhibit 10.2 HESKA CORPORATION EQUITY INCENTIVE PLAN Effective May 5, 2021 ARTICLE 1. INTRODUCTION The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by (a) encouraging Employees, Outside Directors and Consultants to focus on critical long-range objectives, (b) encouraging the attraction and retention of Employees, Outside Directors and |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA CORP |
|
| August 3, 2021 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Second Quarter 2021 Results Record Quarterly Revenue $64.9 Million, North America Lab Consumables Sales Up 42.5% Outlook Raised, New Product Launches and Strategic Initiatives Advanced LOVELAND, CO, August 3, 2021 - Heska Corporation (NASDAQ: HSKA; ?Heska? or ?Company?), |
|
| August 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 August 3, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| June 10, 2021 |
Exhibit 10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Amended and Restated Employment Agreement (the ?Agreement?) is made effective at the Effective Date set forth below between Heska Corporation, a Delaware corporation (?Heska? or the ?Company?), and Kevin S. Wilson (?Executive?) and supersedes and replaces in its entirety that certain employment agreement dated as of March 7, 2018 between |
|
| June 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 June 8, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Comm |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA COR |
|
| May 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 6, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commi |
|
| May 6, 2021 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports First Quarter 2021 Results Record Quarterly Revenue Growth Up 97.4% to $60.5 Million North America Point of Care Lab Consumables Sales Up 23.9% LOVELAND, CO, May 6, 2021 - Heska Corporation (NASDAQ: HSKA; ?Heska? or ?Company?), a leading provider of advanced veterinary d |
|
| May 6, 2021 |
Exhibit 10.1 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 5, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commi |
|
| May 6, 2021 |
As filed with the Securities and Exchange Commission on May 5, 2021 Registration No. |
|
| March 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ |
|
| March 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X |
|
| March 5, 2021 |
Exhibit 1.1 EXECUTION VERSION HESKA CORPORATION 940,860 Shares of Public Common Stock, par value $0.01 per share Underwriting Agreement March 2, 2021 J.P. MORGAN SECURITIES LLC PIPER SANDLER & CO. As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Piper Sandler & Co. 345 Park Avenue, 12th Floor N |
|
| March 5, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2021 HESKA CORPORATION (Exact name of Registrant as Specified in Its Charter) Delaware 000-22427 77-0192527 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| March 4, 2021 |
CALCULATION OF REGISTRATION FEE TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(2) Registration No. 333-253700 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered ? ? Amount to be Registered(1) ? ? Proposed Maximum Offering Price Per Share ? ? Proposed Maximum Aggregate Offering Price ? ? Amount of Registration Fee(2) Common Stock, $0.01 par value per share ? ? 1,081,989 ? ? $186.00 ? ? $201,249,95 |
|
| March 1, 2021 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 1, 2021 Registration No. |
|
| March 1, 2021 |
SUBJECT TO COMPLETION, DATED MARCH 1, 2021 TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. |
|
| February 26, 2021 |
Employment Agreement between Registrant and Christopher Sveen, effective as of April 15, 2020 Exhibit 10.31 EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is made effective on April 15th, 2020 (the "Effective Date") between Heska Corporation, a Delaware corporation ("Heska"), and Christopher Sveen ("Executive"). Heska and Executive collectively are referred to as the "Parties" and individually as a "Party." RECITALS WHEREFORE, Executive is currently the Executive Vice Pre |
|
| February 26, 2021 |
Exhibit 4.2 HESKA CORPORATION DESCRIPTION OF SECURITIES DESCRIPTION OF COMMON STOCK General The following description summarizes important terms of our common stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth herein, you should refer to our Certificate of Incorporation and our bylaws, both |
|
| February 26, 2021 |
Employment Agreement between Registrant and Eleanor Baker, effective as of April 9, 2020 Exhibit 10.32 EMPLOYMENT AGREEMENT This Employment Agreement (the ?Agreement?) is made effective on April 9th, 2020 (the ?Effective Date?) between Heska Corporation, a Delaware corporation (?Heska?), and Eleanor Baker (?Executive?). Heska and Executive collectively are referred to as the ?Parties? and individually as a ?Party.? RECITALS WHEREFORE, Executive is currently the Executive Vice Presiden |
|
| February 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA CORPORAT |
|
| February 26, 2021 |
Exhibit 10.30 SEPARATION AND RELEASE AGREEMENT This Separation and Release Agreement (the "Agreement") is made between (i) Jason Aroesty ("Employee") and (ii) Heska Corporation (the "Company"). Employee and the Company are referred to collectively as the "Parties" and individually as a "Party." RECITALS WHEREAS, Employee was employed at the Company's Loveland facility; , WHEREAS, Employee's employ |
|
| February 26, 2021 |
Amended and Restated Management Incentive Plan Master Document Exhibit 10.15 Heska Corporation Management Incentive Plan Master Document Amended and Restated as of February 17, 2021 This Management Incentive Plan Master Document (?MIP?) is intended to provide incentives to the senior management of Heska Corporation (?Heska? or the ?Company?) for the achievement of goals and objectives that are essential to the growth and continued success of the Company. This |
|
| February 26, 2021 |
Exhibit 21.1 SUBSIDIARIES OF COMPANY Diamond Animal Health, Inc., an Iowa corporation Heska AG, a corporation incorporated under the laws of Switzerland Heska Canada, Limited, a limited company organized under the laws of British Columbia, Canada Heska Australia Pty Ltd, a proprietary company organized under the laws of Australia and registered in Victoria Optomed SAS, a corporation incorporated u |
|
| February 23, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 February 23, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) |
|
| February 23, 2021 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Fourth Quarter and Full Year 2020 Results Full Year Sales Up 60.9% - Fourth Quarter Sales Up 90.5% - Full Year Subscriptions Up 25% 2021 Outlook Revenue Raised, Key Strategic Initiatives Reaffirmed LOVELAND, CO, February 23, 2021 - Heska Corporation (NASDAQ: HSKA; “Heska |
|
| February 16, 2021 |
Heska Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Heska Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 42805E306 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* HESKA Corporation (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securities) 42805E306 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| February 12, 2021 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* HESKA CORP (Name of Issuer) Common (Title of Class of Securities) 42805E306 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Heska Corp. Title of Class of Securities: Common Stock CUSIP Number: 42805E306 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13 |
|
| February 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No.1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 February 4, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation |
|
| January 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 January 12, 2021 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| January 12, 2021 |
Heska Corporation Elects Dr. Joachim Hasenmaier to Board of Directors Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Elects Dr. Joachim Hasenmaier to Board of Directors LOVELAND, CO, January 12, 2021 - Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, appointed Dr. Joachim Hasenmaier, the former head of B |
|
| November 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 18, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) |
|
| November 18, 2020 |
Heska Corporation Elects Robert L. Antin to Board of Directors Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Elects Robert L. Antin to Board of Directors LOVELAND, CO, November 18, 2020 - Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, appointed Robert L. Antin, the Founder of VCA Antech, Inc., |
|
| November 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA |
|
| November 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 5, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| November 5, 2020 |
Exhibit 10.1 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under |
|
| November 5, 2020 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Third Quarter 2020 Results Record Quarterly Revenues Up 81.3% to $56.6 Million North America Diagnostic Consumables Sales Up 15.2% Reaffirms 2020 Combined Outlook and Other Key Targets LOVELAND, CO, November 5, 2020 - Heska Corporation (NASDAQ: HSKA; “Heska” or “Company” |
|
| August 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 August 20, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (C |
|
| August 24, 2020 |
Heska Corporation Elects Stephen L. Davis to Board of Directors Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Elects Stephen L. Davis to Board of Directors LOVELAND, CO, August 24, 2020 - Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading global provider of advanced veterinary diagnostic and specialty products, appointed Stephen Davis, the Chairman and Founder of the Will |
|
| August 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA CORP |
|
| August 10, 2020 |
Exhibit 10.2 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under |
|
| August 10, 2020 |
Exhibit 10.1 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under |
|
| August 10, 2020 |
Employment Agreement between Registrant and Steven M. Eyl, effective as of April 16, 2020 .3 Exhibit 10.3 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made effective on 4/16/2020, 2020 (the “Effective Date”) between Heska Corporation, a Delaware corporation (“Heska”), and Steve Eyl (“Executive”). Heska and Executive collectively are referred to as the “Parties” and individually as a “Party.” RECITALS WHEREFORE, Executive is currently the Executive Vice President, |
|
| August 4, 2020 |
Exhibit 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Second Quarter 2020 Results Record Quarterly Revenues Up 62.4% to $45.7 Million Reaffirms 2020 Consolidated Revenues and Other Key Targets LOVELAND, CO, August 4, 2020 - Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading provider of advanced veterinary dia |
|
| August 4, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 August 4, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| May 28, 2020 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 21, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Comm |
|
| May 28, 2020 |
Letter from Plante & Moran, PLLC dated May 21, 2020 to the Securities and Exchange Commission a8kchangeinaccountantsle May 21, 2020 Securities and Exchange Commission 100 F Street, NE Washington, D. |
|
| May 12, 2020 |
Heska Corporation 3760 Rocky Mountain Avenue Loveland, Colorado 80538 (970) 493-7272 May 12, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N. |
|
| May 8, 2020 |
2020 Employee Stock Purchase Plan of Registrant, as amended and restated. EXHIBIT 10.1 HESKA CORPORATION 2020 EMPLOYEE STOCK PURCHASE PLAN 1. Purpose. The purpose of the 2020 Employee Stock Purchase Plan (the “Plan”) is to provide an opportunity for Employees of Heska Corporation, a Delaware corporation (the “Company”) and its Participating Subsidiaries to purchase Common Stock and thereby to have an additional incentive to contribute to the prosperity of the Company. I |
|
| May 8, 2020 |
EXHIBIT 10.2 HESKA CORPORATION STOCK INCENTIVE PLAN Most Recently Amended and Restated effective April 8, 2020 1 Heska Corporation Stock Incentive Plan Most Recently Amended and Restated effective April 8, 2020 Table of Contents ARTICLE 1. INTRODUCTION 4 ARTICLE 2. ADMINISTRATION 4 2.1 Committee Composition 4 2.2 Committee Responsibilities 4 2.3 Indemnification 5 2.4 Beneficiary Designations 5 ART |
|
| May 8, 2020 |
Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of Registrant. Exhibit 3.2 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, OF HESKA CORPORATION Heska Corporation (the "Corporation"), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the "DGCL"), does hereby certify: 1. This Certificate of Amendment to the Corporation’s Restated Certificate of Incorporation, as a |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA COR |
|
| May 7, 2020 |
Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Corporation Reports First Quarter 2020 Results Revenue $30.7 Million, Diagnostic Consumable Sales up 15.7% Strong Balance Sheet, Fundamentals, Global Position Drive Strategy LOVELAND, CO, May 7, 2020 - Heska Corporation (NASDAQ: HSKA; “Heska” or “Company”), a leading provider of a |
|
| May 7, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 7, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 6, 2020 |
ex992scilauditedfinancia Exhibit 99.2 SCIL ANIMAL CARE COMPANY GMBH AND SUBSIDIARIES INDEX TO COMBINED FINANCIAL STATEMENTS Page Report of Independent Auditors 2 Combined Balance Sheets 3 Combined Statements of Operations 4 Combined Statements of Comprehensive Income 5 Combined Statements of Equity 6 Combined Statements of Cash Flows 7 Notes to Combined Financial Statements 8 1 Telefon +49 69 9594 |
|
| May 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 16 of The Securities Exchange Act of 1934 April 16, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 6, 2020 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 March 30, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File |
|
| May 6, 2020 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction On April 1, 2020, Heska Corporation (“Heska” or the “Company”) completed its previously announced acquisition (“Acquisition”) of 100% of the capital stock of scil animal care company GmbH (“scil”) from Covetrus Animal Health Holdings Limited (the “Seller”), a subsidiary of Covetrus, Inc. (“Covetrus”), pursuant t |
|
| May 5, 2020 |
Heska Corporation 2020 Employee Stock Purchase Plan Exhibit 99.1 HESKA CORPORATION 2020 EMPLOYEE STOCK PURCHASE PLAN 1. Purpose. The purpose of the 2020 Employee Stock Purchase Plan (the “Plan”) is to provide an opportunity for Employees of Heska Corporation, a Delaware corporation (the “Company”) and its Participating Subsidiaries to purchase Common Stock and thereby to have an additional incentive to contribute to the prosperity of the Company. I |
|
| May 5, 2020 |
2020 Employee Stock Purchase Plan. As filed with the Securities and Exchange Commission on May 5, 2020 Registration No. |
|
| May 5, 2020 |
Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of Registrant** Exhibit 3.8 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, OF HESKA CORPORATION Heska Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. This Certificate of Amendment to the Corporation’s Restated Certificate of Incorporation, as a |
|
| May 5, 2020 |
Heska Corporation Stock Incentive Plan (most recently amended and restated effective April 8, 2020). Exhibit 99.1 HESKA CORPORATION STOCK INCENTIVE PLAN (as proposed to be amended) 1 Heska Corporation Stock Incentive Plan Most Recently Amended and Restated effective April 8, 2020 Table of Contents ARTICLE 1. INTRODUCTION 4 ARTICLE 2. ADMINISTRATION 4 2.1 Committee Composition 4 2.2 Committee Responsibilities 4 2.3 Indemnification 5 2.4 Beneficiary Designations 5 ARTICLE 3. SHARES AVAILABLE FOR GR |
|
| May 5, 2020 |
As filed with the Securities and Exchange Commission on May 5, 2020 Registration No. |
|
| May 5, 2020 |
Heska Corporation Stock Incentive Plan (as amended and restated effective April 8, 2020). As filed with the Securities and Exchange Commission on May 5, 2020 Registration No. |
|
| April 27, 2020 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 21, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| April 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 16, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| April 22, 2020 |
Heska Corporation Expands Executive Leadership Team EXHIBIT 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Expands Executive Leadership Team LOVELAND, CO, April 22, 2020 - Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today that it will expand its leadership team, adding a Chief Commercial Of |
|
| April 9, 2020 |
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of them of a statement on Schedule 13G (including amendments thereto) with respect to the shares of Common Stock, par value $0. |
|
| April 9, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 April 8, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Com |
|
| April 9, 2020 |
HSKA / Heska Corp. / Park West Asset Management LLC - HESKA CORP 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* HESKA Corporation (Name of Issuer) COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securities) 42805E306 (CUSIP Number) March 30, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| April 1, 2020 |
Certain personally identifiable information, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K. |
|
| April 1, 2020 |
EXHIBIT 99.1 Heska Corporation Jon Aagaard Investor Relations 970.619.3033 [email protected] Heska Corporation Completes Acquisition of scil animal care to Create a Global Leader in Veterinary Point-of-Care Diagnostics Jumps to #1 or #2 in key markets and expands reach to 25 countries LOVELAND, CO, April 1, 2020 - Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a provider of |
|
| April 1, 2020 |
EXHIBIT 2.1 Certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K. AMENDMENT AGREMENT regarding the agreement on the sale and purchase of the sole share in scil animal care company GmbH This amendment agreement (the “Amendment Agreement”) is made on April 1, 2020 BETWEE |
|
| April 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 March 30, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Co |
|
| April 1, 2020 |
Amendment to the Securities Purchase Agreement dated March 30, 2020 EXHIBIT 10.1 Execution Version AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT This AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT (this “Amendment”), dated as of March 30, 2020, is entered into by and among HESKA CORPORATION, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectivel |
|
| April 1, 2020 |
Certain personally identifiable information, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K. |
|
| March 25, 2020 |
HSKA / Heska Corp. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ |
|
| March 2, 2020 |
HSKA / Heska Corp. DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X |
|
| February 28, 2020 |
Exhibit 10.39 SEPARATION AND RELEASE AGREEMENT This Separation and Release Agreement (the “Agreement”) is made between (i) Rod Lippincott (“Employee”) and (ii) Heska Corporation (the “Company”). Employee and the Company are referred to collectively as the “Parties” and individually as a “Party.” RECITALS WHEREAS, Employee was employed at the Company’s Loveland facility; WHEREAS, Employee’s employm |
|
| February 28, 2020 |
Exhibit 4.2 HESKA CORPORATION DESCRIPTION OF SECURITIES DESCRIPTION OF COMMON STOCK General The following description summarizes important terms of our common stock. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description of the matters set forth herein, you should refer to our Certificate of Incorporation and our bylaws, both |
|
| February 28, 2020 |
Exhibit 10.57 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. THIRD AMENDMENT TO CLINICAL CHEMISTRY ANALYZER AGREEMENT This Third Amendment to Clinical Chemistry Analyzer Agreement (the “Amendment”), entered into as of August 27th, 2019, modi |
|
| February 28, 2020 |
Exhibit 10.68 Certain personally identifiable information, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under Regulation S-K. SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of January 12, 2020 by and among HESKA CORPORATION, a Delaware corporation (the “Company”), and each purchaser identified on the sig |
|
| February 28, 2020 |
Exhibit 10.26 SEPARATION AND RELEASE AGREEMENT This Separation and Release Agreement (the “Agreement”) is made between (i) Jason Napolitano (“Employee”) and (ii) Heska Corporation (the “Company”). Employee and the Company are referred to collectively as the “Parties” and individually as a “Party.” RECITALS WHEREAS, Employee was employed at the Company’s Loveland facility; WHEREAS, Employee’s emplo |
|
| February 28, 2020 |
Exhibit 10.35 SEPARATION AND RELEASE AGREEMENT This Separation and Release Agreement (the “Agreement”) is made between (i) Steve Asakowicz (“Employee”) and (ii) Heska Corporation (the “Company”). Employee and the Company are referred to collectively as the “Parties” and individually as a “Party.” RECITALS WHEREAS, Employee was employed at the Company’s Loveland facility; WHEREAS, Employee’s employ |
|
| February 28, 2020 |
HSKA / Heska Corp. 10-K - Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-22427 HESKA CORPORAT |
|
| February 28, 2020 |
Exhibit 21.1 SUBSIDIARIES OF COMPANY Diamond Animal Health, Inc., an Iowa corporation Heska Imaging, LLC, a Delaware Limited Liability Company Heska AG, a corporation incorporated under the laws of Switzerland Heska Canada, Limited, a corporation organized under the laws of British Columbia, Canada Heska Australia Pty Ltd, a proprietary company organized under the laws of Australia and registered |
|
| February 28, 2020 |
Exhibit 10.16 HESKA CORPORATION DIRECTOR COMPENSATION POLICY Non-employee directors of Heska Corporation, a Delaware corporation (the "Company") shall receive the following compensation for their service as a member of the Board of Directors (the "Board") of the Company: Cash Compensation Annual Retainer for General Board Service Effective April 1, 2020, each non-employee director shall be entitle |
|
| February 28, 2020 |
Exhibit 2.1 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. In addition, certain personally identifiable information contained in this document, marked by brackets as [***], has been omitted from this exhibit pursuant to Item 601(a)(6) under |
|
| February 25, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 February 25, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File |
|
| February 25, 2020 |
Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Fourth Quarter and Full Year 2019 Results Full Year 2019 Revenue $122.7 Million Full Year 2019 Diagnostic Consumable Sales up 19.7% Core Lab Diagnostics Above 2019 Outlook Drives Strong Full Year Results LOVELAND, CO, February 25, 2020 - Heska Corporation (NASD |
|
| February 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [X] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ |
|
| February 14, 2020 |
HSKA / Heska Corp. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* HESKA CORP (Name of Issuer) Common (Title of Class of Securities) 42805E306 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 14, 2020 |
HSKA / Heska Corp. / Alger Associates Inc - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Heska Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 42805E306 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu |
|
| February 12, 2020 |
HSKA / Heska Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Heska Corp Title of Class of Securities: Common Stock CUSIP Number: 42805E306 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d |
|
| January 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 January 20, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| January 15, 2020 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No.) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 January 12, 2020 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| November 6, 2019 |
HSKA / Heska Corp. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-22427 HESKA C |
|
| November 5, 2019 |
Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Corporation Reports Third Quarter 2019 Results Revenue $31.2 Million, Diagnostic Consumables Sales up 20.9% New Product Launches and Core Business Growth Initiatives Reiterated LOVELAND, CO, November 5, 2019 - Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a pr |
|
| November 5, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 November 5, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File |
|
| September 17, 2019 |
Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Corporation Announces Pricing of $75.0 million of 3.750% Convertible Senior Notes due 2026 LOVELAND, CO, September 12, 2019 – Heska Corporation (Nasdaq: HSKA; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty healthcare products, today announced |
|
| September 17, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 September 12, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission Fil |
|
| September 17, 2019 |
Exhibit 4.1 EXECUTION VERSION HESKA CORPORATION and U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of September 17, 2019 3.750% Convertible Senior Notes due 2026 1 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01 . Definitions 1 Section 1.02 . References to Interest 13 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND EXCHANGE OF NOTES Section 2.01 . Designation and |
|
| September 11, 2019 |
Heska Corporation Announces Proposed Private Offering of $75.0 Million of Convertible Senior Notes Exhibit 99.2 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Corporation Announces Proposed Private Offering of $75.0 Million of Convertible Senior Notes LOVELAND, CO, September 11, 2019 – Heska Corporation (Nasdaq: HSKA; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty healthcare products, today announc |
|
| September 11, 2019 |
FOURTH AMENDMENT TO CREDIT AGREEMENT EX-99.1 2 exhibit991-fourthamendment.htm EXHIBIT 99.1 Exhibit 99.1 FOURTH AMENDMENT TO CREDIT AGREEMENT This Fourth Amendment to Credit Agreement, dated as of September 9, 2019 (this “Amendment”), is among HESKA CORPORATION, DIAMOND ANIMAL HEALTH, INC. and HESKA IMAGING, LLC (the “Borrowers”), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administ |
|
| September 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 September 9, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File |
|
| August 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No. ) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 August 29, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 001-22427 77-0192527 (State or other jurisdiction of incorporation) ( |
|
| August 9, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 2, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 001-22427 77-0192527 (State or other jurisdiction of incorporation) (C |
|
| August 7, 2019 |
Exhibit 10.6 THIRD AMENDMENT TO CREDIT AGREEMENT This Third Amendment to Credit Agreement, dated as of July 16, 2019 (this "Amendment"), is among HESKA CORPORATION, DIAMOND ANIMAL HEALTH, INC. and HESKA IMAGING, LLC (the “Borrowers”), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”). |
|
| August 7, 2019 |
Heska Corporation Stock Incentive Plan, as amended and restated. Exhibit 10.4 HESKA CORPORATION STOCK INCENTIVE PLAN i HESKA CORPORATION STOCK INCENTIVE PLAN MOST RECENTLY AMENDED AND RESTATED EFFECTIVE MAY 2, 2019 TABLE OF CONTENTS ARTICLE 1. INTRODUCTION1 ARTICLE 2. ADMINISTRATION.1 2.1Committee Composition 1 2.2Committee Responsibilities 2 2.3Indemnification 2 2.4Beneficiary Designations 2 ARTICLE 3. SHARES AVAILABLE FOR GRANTS.2 3.1Basic Limitation 2 3.2Add |
|
| August 7, 2019 |
Exhibit 10.2 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. AMENDMENT TO ASSET PURCHASE and LICENSE AGREEMENT This AMENDMENT TO ASSET PURCHASE and LICENSE AGREEMENT (this "Amendment") is entered into effective upon the date of last signature |
|
| August 7, 2019 |
Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of Registrant. Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, OF HESKA CORPORATION Heska Corporation (the "Corporation"), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the "DGCL"), does hereby certify: 1. This Certificate of Amendment to the Corporation’s Restated Certificate of Incorporation, as a |
|
| August 7, 2019 |
Amended and Restated Bylaws of the Registrant, as amended. Exhibit 3.2 Amended and Restated Bylaws as approved on May 2, 2019. B Y L A W S OF HESKA CORPORATION (a Delaware corporation) -i- ARTICLE 1 Offices 1.1 Principal Office. The registered office of the corporation shall be 1209 Orange Street, Wilmington, Delaware. 1.2 Additional Offices. The corporation may also have offices at such other places, either within or without the State of Delaware, as the |
|
| August 7, 2019 |
Exhibit 10.3 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. AMENDMENT NO. 2 TO THE ASSET PURCHASE AND LICENSE AGREEMENT BETWEEN ELANCO US INC. AND DIAMOND ANIMAL HEALTH, INC Elanco US Inc. (“Elanco”) (formerly Elanco Animal Health a division |
|
| August 7, 2019 |
HSKA / Heska Corp. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-22427 HESKA CORPOR |
|
| August 7, 2019 |
Exhibit 10.1 Certain confidential information contained in this document, marked by brackets as [***], has been omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. AMENDMENT NO. 1 TO THE SUPPLEMENTAL AGREEMENT BETWEEN ELANCO US INC. AND DIAMOND ANIMAL HEALTH, INC Elanco US Inc. (“Elanco”) (formerly Eli Lilly and Company and its Affiliates oper |
|
| August 6, 2019 |
Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Reports Second Quarter 2019 Results Revenue $28.1 Million, Diagnostic Consumables Sales up 14.6% Full Year Outlook, New Product Launches and Core Business Growth Initiatives Reiterated LOVELAND, CO, August 6, 2019 - Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”) |
|
| August 6, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 August 6, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 4, 2019 |
Exhibit 99.1 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made effective on June 1st, 2019 (the “Effective Date”) between Heska Corporation, a Delaware corporation (“Heska”), and Catherine Grassman (“Executive”). Heska and Executive collectively are referred to as the “Parties” and individually as a “Party.” RECITALS WHEREFORE, Executive is currently the Executive Vice Presi |
|
| June 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 June 1, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 8, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 2, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 8, 2019 |
HSKA / Heska Corp. 10-Q Quarterly Report 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-22427 HESKA CORPO |
|
| May 7, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 7, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 7, 2019 |
Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Reports First Quarter 2019 Results Revenue $29.5 Million, Margins Solid, Multi-Year Highs in Subscriptions Gains Management Reiterates Full Year Outlook, New Product Launches and Core Business Growth Initiatives LOVELAND, CO, May 7, 2019 - Heska Corporation (NASDAQ: HSKA - News; “ |
|
| May 6, 2019 |
Heska Names Chief Financial Officer to Enhance Executive Team Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Heska Names Chief Financial Officer to Enhance Executive Team LOVELAND, CO, May 6, 2019 - Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today announced the promotion of Catherine Grassman from Vice |
|
| May 6, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 May 6, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| April 29, 2019 |
HSKA / Heska Corp. / HESKA CORP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) HESKA CORPORATION (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 42805E-306 (CUSIP Number) Kevin S. Wilson 3760 Rocky Mountain Avenue Loveland, CO 80538 (970) 775-2247 With a copy to: Rudolph C. Shepard Stradling |
|
| March 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X |
|
| March 21, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 March 15, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [] Check the appropriate box: [X] Preliminary Proxy Statement [] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [ |
|
| March 8, 2019 |
8-K 1 furlong8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 March 8, 2019 Date of Report (Date of earliest event reported) HESKA CORPORATION (Exact name of Registrant as specified in its charter) Delaware 000-22427 77-0192527 (State or other jurisdiction of incorporat |
|
| March 8, 2019 |
Mark Furlong Joins Heska’s Board of Directors Exhibit 99.1 Heska Corporation Jon Aagaard Director, Investor Relations 970.619.3033 [email protected] Mark Furlong Joins Heska’s Board of Directors LOVELAND, CO, March 8, 2019 - Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that Mark Furlong has joined the Company’s Board of Directors (th |
|
| March 8, 2019 |
HSKA / Heska Corp. / Alger Associates Inc - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Heska Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 42805E306 (CUSIP Number) February 28, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| March 7, 2019 |
Exhibit 21.1 SUBSIDIARIES OF COMPANY Diamond Animal Health, Inc., an Iowa corporation Heska Imaging, LLC, a Delaware Limited Liability Company Heska AG, a corporation incorporated under the laws of Switzerland Heska Canada, Limited, a corporation organized under the laws of British Columbia, Canada Heska Australia Pty Ltd, a proprietary company organized under the laws of Australia and registered |
|
| March 7, 2019 |
Stock Incentive Plan Restricted Stock Grant Agreement (Performance-based Award). Exhibit 10.3 HESKA CORPORATION STOCK INCENTIVE PLAN RESTRICTED STOCK GRANT AGREEMENT THIS AGREEMENT is made as of the day of , 20 (the “Grant Date”) by and between Heska Corporation (the “Company”) and (the “Executive”). In consideration of the mutual covenants and representations herein set forth, the Company and Executive agree as follows: SECTION 1. GRANT OF RESTRICTED STOCK. 1.1. Precedence of |
|
| March 7, 2019 |
HSKA / Heska Corp. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 0-22427 HESKA CORPORATIO |
|
| March 7, 2019 |
Stock Incentive Plan Outside Directors Option Agreement. Exhibit 10.7 Heska Corporation Stock Incentive Plan (the “Plan”) Stock Option Agreement (this “Agreement”) (Outside Directors) Award This Award consists of an Option to purchase the number of Common Shares set forth on the Notice of Stock Option Grant, to which this Agreement is attached, at the Exercise Price per Common Share stated therein, which is not less than one-hundred percent (100%) of th |
|
| March 7, 2019 |
Stock Incentive Plan Employees and Consultants Option Agreement. Exhibit 10.6 Heska Corporation Stock Incentive Plan (the “Plan”) Stock Option Agreement (this “Agreement”) (Employees and Consultants) Award This Award consists of an Option to purchase the number of Common Shares set forth on the Notice of Stock Option Grant, to which this Agreement is attached, at the Exercise Price per Common Share stated therein, which is not less than one-hundred percent (100 |
|
| March 7, 2019 |
Stock Incentive Plan Restricted Stock Grant Agreement (Outside Director Award). Exhibit 10.5 HESKA CORPORATION STOCK INCENTIVE PLAN RESTRICTED STOCK GRANT AGREEMENT (Outside Director Award) THIS AGREEMENT is made as of the day of , 20 (the “Grant Date”) by and between Heska Corporation (the “Company”) and (the “Director”). In consideration of the mutual covenants and representations herein set forth, the Company and Director agree as follows: SECTION 1. GRANT OF RESTRICTED ST |
|
| March 7, 2019 |
Stock Incentive Plan Restricted Stock Grant Agreement (Management Incentive Plan Award). Exhibit 10.4 HESKA CORPORATION STOCK INCENTIVE PLAN RESTRICTED STOCK GRANT AGREEMENT (Management Incentive Plan Award) THIS AGREEMENT is made as of the day of , 20 (the “Grant Date”) by and between Heska Corporation (the “Company”) and (the “Executive”), in connection with the Executive’s election to receive a portion of Executive’s award under the Management Incentive Plan (the “MIP”) in the form |
